Filter
643
Filtered Results: 643
Text search:
nucleic
Acid
Featured
Recommendations
111
New Publications
158
Language
Document type
No document type
320
Guidelines
159
Studies & Reports
83
Manuals
44
Fact sheets
18
Training Material
6
Strategic & Response Plan
6
Situation Updates
3
Infographics
2
Resource Platforms
1
Videos
1
Countries / Regions
India
42
Western and Central Europe
19
Global
17
Tanzania
12
South Africa
11
Eastern Europe
11
Africa
10
Latin America and the Carribbean
9
Ethiopia
9
Brazil
8
Nigeria
7
Nepal
6
Kenya
6
Liberia
6
Rwanda
5
Peru
5
East and Southern Africa
5
Bangladesh
5
Zambia
5
Myanmar / Burma
5
Ukraine
4
Asia
4
Congo, Democratic Republic of
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Russia
4
Angola
4
Colombia
3
El Salvador
3
Sierra Leone
3
Senegal
3
Germany
3
Argentina
3
Uganda
3
Namibia
3
China
2
Cameroon
2
Syria
2
Philippines
2
Guinea
2
Mozambique
2
Middle East and North Africa
2
South–East Asia Region
2
Portugal
2
Vietnam
2
Pakistan
2
Timor Leste/ East Timor
1
Lesotho
1
Turkey
1
Ghana
1
Burkina Faso
1
Afghanistan
1
Italy
1
USA
1
Haiti
1
Cambodia
1
Western Pacific Region
1
Uruguay
1
France
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Moldova
1
Sri Lanka
1
Georgia
1
Chad
1
Bhutan
1
Botswana
1
South Sudan
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
163
Clinical Guidelines
113
Pharmacy & Technologies
46
Public Health
19
Key Resources
18
Women & Child Health
14
Capacity Building
4
Toolboxes
TB
128
COVID-19
112
HIV
75
NTDs
49
Rapid Response
44
Ebola & Marburg
23
Zika
17
AMR
15
Refugee
13
Pharmacy
12
Polio
6
Mental Health
4
Specific Hazards
4
Caregiver
4
Planetary Health
4
Conflict
3
Natural Hazards
2
Health Financing Toolbox
2
NCDs
2
Global Health Education
1
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog...
4–15 February 2013
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im...
29 Dec 2021. Comprehensive slideset updated regularly to include the latest data and guidance on best practices for COVID-19 diagnosis and prevention of COVID-19 transmission.
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Tuberculosis (TB)
recommended
MEDBOX Issue Brief no. 19: World TB Day: Invest to end TB. Save Lives
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
This document provides a list of key WHO-recommended maternal and newborn health commodities and aims to accelerate progress towards the SDGs. It consolidates the key and enabling commodities from existing WHO guidelines on maternal and newborn health.
5th edition.
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Epidemic meningitis is a major public health challenge in the African 'meningitis belt', an area that extends from Senegal to Ethiopia with an estimated total population of 500 million. Since 2002, the World Health Organization (WHO), in collaboration with its collaborating centres for meningitis, h...
